| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/04/2009 | US7569581 Anticholinergics which may be used as medicaments as well as processes for preparing them |
| 08/04/2009 | US7569570 N-{4-[1-(2,6-difluorobenzyl)-3-(4-fluorophenyl)-5-({methy[2-(2-oxo-1-piperidinyl)ethyl]amino}methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-N'-ethylurea; antagonistic action for gonadotropin-releasing hormone |
| 08/04/2009 | US7569566 Inhibitors of tyrosine kinases |
| 08/04/2009 | US7569564 Such as 4-(4,4-Dimethyl-2-thioxo-1,4-dihydro-2H-benzo[d][1 ,3]oxazin-6-yl)-thiophene-2-carbonitrile; estrogen receptor agonists, progesterone receptor antagonists; hormone replacement therapy |
| 08/04/2009 | US7569351 P53 dependent apoptosis-associated gene and protein |
| 08/04/2009 | US7569227 Monomeric protein of the TGF-β family |
| 08/04/2009 | CA2496476C Therapeutic use |
| 08/04/2009 | CA2462606C Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 08/04/2009 | CA2434228C Biphenyl derivatives |
| 08/04/2009 | CA2433785C Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/04/2009 | CA2424566C Dental care compositions |
| 08/04/2009 | CA2406057C Methods and compositions for modulating alpha adrenergic receptor activity |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 08/04/2009 | CA2356212C Crystalline bis[(e)-7- [ 4-(4- fluorophenyl)- 6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin -5-yl] (3r,5s)-3, 5-dihydroxyhept -6-enoic acid]calcium salt |
| 08/04/2009 | CA2334727C Tetrahydroquinoline derivatives as glycine antagonists |
| 08/04/2009 | CA2323090C In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
| 08/04/2009 | CA2320959C Cytokine inducers comprising m161ag |
| 08/04/2009 | CA2207850C Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 07/30/2009 | WO2009094177A1 Protopanaxadiol-type ginsenoside compositions and uses thereof |
| 07/30/2009 | WO2009094157A1 Dihydro- 1h- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| 07/30/2009 | WO2009093761A1 Medicinal composition for inhibiting amyloid-β protein deposition |
| 07/30/2009 | WO2009093755A1 Agent for increasing blood adiponectin quantity |
| 07/30/2009 | WO2009093737A1 Anti-obesity pharmaceutical composition |
| 07/30/2009 | WO2009093735A1 Pharmaceutical composition |
| 07/30/2009 | WO2009093629A1 Prophylactic or therapeutic agent for malaria |
| 07/30/2009 | WO2009093584A1 Plant-origin drug for preventing or improving hyperuricemia |
| 07/30/2009 | WO2009093534A1 Vegfc production promoter |
| 07/30/2009 | WO2009093533A1 IgE ANTIBODY PRODUCTION INHIBITOR |
| 07/30/2009 | WO2009093471A1 Apoptosis inhibitor |
| 07/30/2009 | WO2009093463A1 Neuronal cell death inhibitor |
| 07/30/2009 | WO2009093454A1 Food composition, feed composition comprising the food composition, and method for feeding animal by using the feed composition |
| 07/30/2009 | WO2009093447A1 Anti-tumor agent for gastrointestinal cancer |
| 07/30/2009 | WO2009093353A1 Medicinal composition |
| 07/30/2009 | WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof |
| 07/30/2009 | WO2008101406A8 Modified mutant collagenase and it's use in fat melting and in scar reduction |
| 07/30/2009 | WO2008073957A8 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 07/30/2009 | US20090192320 a polyalkylene glycol derivative having a reactive group, which can be combined with a bio-related substance, at the primary carbon at the 1-position of a glycerin skeleton and having polyalkylene glycol chains at the 2- and 3-positions |
| 07/30/2009 | US20090192293 Antibodies to non-functional p2x7 receptor |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192211 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 07/30/2009 | US20090192206 Mercaptoimidazoles as ccr2 receptor antagonists |
| 07/30/2009 | US20090192177 2-ARYL pyrrologpyrimidines for A1 and A3 receptors |
| 07/30/2009 | US20090192148 Organic Compounds |
| 07/30/2009 | US20090192121 Novel bisamidate phosphonate prodrugs |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090192082 Cxcr4 antagonist treatment of hematopoietic cells |
| 07/30/2009 | US20090192081 Casein derived peptides and uses thereof |
| 07/30/2009 | US20090191640 Methods of Screening for Atherosclerosis |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191203 Bcma Polypeptides And Uses Thereof |
| 07/30/2009 | US20090191146 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | CA2713104A1 Protopanaxadiol-type ginsenoside compositions and uses thereof |
| 07/30/2009 | CA2712910A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 07/30/2009 | CA2711887A1 Dihydro-1h-pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| 07/29/2009 | EP2083267A1 Diagnosis and treatment of autism using cd38 |
| 07/29/2009 | EP2083076A1 In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitution |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 07/29/2009 | EP2082743A2 Inhibitors of GSK-3 and crystal structures of GSK-3beta protein and protein complexes |
| 07/29/2009 | EP2082740A2 Use of imidazole derivatives as MDR modulators |
| 07/29/2009 | EP2082737A2 Methods of inducing terminal differentiation |
| 07/29/2009 | EP2081917A2 Cytochrome p450 oxidase inhibitors and uses thereof |
| 07/29/2009 | EP2005951A9 Agent for improving nervous system cell functions |
| 07/29/2009 | EP1686119B1 Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors |
| 07/29/2009 | EP1513527B1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers |
| 07/29/2009 | EP1409468B9 Guanidinobenzamides as mc4-r agonists |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1401473B1 Transporters comprising spaced arginine moieties |
| 07/29/2009 | EP1399221B1 Compositions comprising oestrone-3-o-sulphamate and trail (tnf-related apoptosis inducing ligand) |
| 07/29/2009 | EP1389043B1 Foot and mouth disease virus vaccine |
| 07/29/2009 | EP1307223B1 Parenteral vaccine formulations and uses thereof |
| 07/29/2009 | EP1292676B1 Mutation associated with epilepsy |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | EP1189641B1 HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 07/29/2009 | CN101492416A Compounds effecting glucokinase |
| 07/29/2009 | CN101491536A Therapeutically useful synthetic oligonucleotides |
| 07/29/2009 | CN101491520A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 07/29/2009 | CN100519561C Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol |
| 07/29/2009 | CN100519558C Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and the use thereof in the production of a medicament |
| 07/29/2009 | CN100519555C Novel indole derivative for alkylating specific base sequence of DNA, alkylating agent using the same and medicament |
| 07/29/2009 | CN100519554C CCR5 antagonists for treating aids |
| 07/29/2009 | CN100519553C Inhiitors of cyclin dependent kinases as anti-cancer agent |
| 07/29/2009 | CN100519552C Pyrazole compounds |
| 07/29/2009 | CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3 |
| 07/29/2009 | CN100519549C Pyrimidine derivatives and pharmaceutical compositions containing the compounds |
| 07/29/2009 | CN100519539C N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100519526C Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/29/2009 | CN100518820C A Pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
| 07/29/2009 | CN100518747C Matrix metalloprotease inhibitor |
| 07/29/2009 | CN100518741C Pregnane steroids for use in the treatment of cns dysfunction |
| 07/29/2009 | CN100518739C A retroviral immunotherapy |
| 07/28/2009 | US7566791 Substituted 3-carbonyl-1h-indol-1yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566778 Central nervous system disorders; psychological disorders |
| 07/28/2009 | US7566766 Use of phage display libraries in a screening assay in order to determine the identity of peptides sequences which enhance the delivery of the bacteriophage through tissue, such as epithelial cells lining the lumen of gastrointestinal tract |